IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,812 | +171.7% | 114,155 | +222.8% | 0.16% | +131.3% |
| Q2 2023 | $667 | +485.1% | 35,364 | +18.7% | 0.07% | +509.1% |
| Q1 2023 | $114 | -100.0% | 29,800 | -20.9% | 0.01% | -68.6% |
| Q4 2021 | $280,000 | +81.8% | 37,682 | +38.3% | 0.04% | +118.8% |
| Q3 2021 | $154,000 | -59.7% | 27,240 | -75.7% | 0.02% | -83.3% |
| Q1 2020 | $382,000 | +267.3% | 112,009 | +447.7% | 0.10% | +700.0% |
| Q4 2019 | $104,000 | -61.9% | 20,452 | -64.0% | 0.01% | -61.3% |
| Q4 2018 | $273,000 | -75.9% | 56,800 | -51.2% | 0.03% | -44.6% |
| Q2 2018 | $1,133,000 | -50.8% | 116,400 | -46.9% | 0.06% | -54.1% |
| Q1 2018 | $2,305,000 | +33.0% | 219,100 | -19.0% | 0.12% | +16.2% |
| Q4 2017 | $1,733,000 | +89.0% | 270,434 | +125.7% | 0.10% | +69.4% |
| Q3 2017 | $917,000 | -6.9% | 119,824 | -13.5% | 0.06% | -3.1% |
| Q2 2017 | $985,000 | +197.6% | 138,526 | +62.0% | 0.06% | +255.6% |
| Q1 2017 | $331,000 | +324.4% | 85,526 | +124.3% | 0.02% | +260.0% |
| Q4 2016 | $78,000 | – | 38,126 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,477,879 | $37,720,000 | 0.69% |
| QVT Financial LP | 1,375,900 | $4,953,000 | 0.60% |
| RA Capital Management | 7,040,485 | $25,346,000 | 0.46% |
| Birchview Capital, LP | 380,000 | $1,368,000 | 0.46% |
| XTX MARKETS LLC | 18,861 | $68,000 | 0.33% |
| Fernwood Investment Management, LLC | 154,340 | $556,000 | 0.26% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $375,000 | 0.14% |
| Virtus ETF Advisers LLC | 70,213 | $253,000 | 0.13% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,251,458 | $4,505,000 | 0.13% |
| Assenagon Asset Management S.A. | 4,987,334 | $17,954,000 | 0.10% |